Skip to main navigation Skip to search Skip to main content

OVA2-001-C03: marker Discovery and Clinical Trial Testing for OVA2 using Serum from Women with a Documented Ovarian Adnexal Mass

Grants and Contracts Details

StatusFinished
Effective start/end date11/17/10 → 11/10/12

Funding

  • PrecisionMed Inc: $18,712.00